艾拉迪医疗

最新新闻

• 评级变动
  Roth MKM Initiates IRadimed(IRMD.US) With Buy Rating, Announces Target Price $90
  \u5e02\u573a\u8d44\u8baf · 2025/10/31
• 评级变动
  Lake Street Maintains IRadimed(IRMD.US) With Buy Rating, Maintains Target Price $100
  \u5e02\u573a\u8d44\u8baf · 2026/2/7
• 评级变动
  Lake Street Initiates IRadimed(IRMD.US) With Buy Rating, Announces Target Price $70
  \u5e02\u573a\u8d44\u8baf · 2025/2/10
• 评级变动
  Roth MKM Maintains IRadimed(IRMD.US) With Buy Rating, Raises Target Price to $98
  \u5e02\u573a\u8d44\u8baf · 2025/11/4
• 评级变动
  Roth MKM Maintains IRadimed(IRMD.US) With Buy Rating, Raises Target Price to $72
  \u5e02\u573a\u8d44\u8baf · 2025/2/14
• Needham Initiates IRadimed(IRMD.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/22
• Lake Street Maintains IRadimed(IRMD.US) With Buy Rating, Maintains Target Price $120
  \u5e02\u573a\u8d44\u8baf · 2026/8/3
• Earnings Flash (IRMD) IRADIMED CORPORATION Reports Q2 Revenue $20.5M, Vs. FactSet Est of $20.4M
  MT Newswires · 2026/7/31
• 评级变动
  Roth MKM Maintains IRadimed(IRMD.US) With Buy Rating, Maintains Target Price $98
  \u5e02\u573a\u8d44\u8baf · 2025/11/4
• Earnings Flash (IRMD) IRADIMED CORPORATION Posts Q2 Adjusted EPS $0.46, Vs. FactSet Est of $0.44
  MT Newswires · 2026/7/31
• 评级变动
  Roth MKM Maintains IRadimed(IRMD.US) With Buy Rating, Maintains Target Price $120
  \u5e02\u573a\u8d44\u8baf · 2026/2/11
• 评级变动
  Roth MKM Maintains IRadimed(IRMD.US) With Buy Rating, Maintains Target Price $72
  \u5e02\u573a\u8d44\u8baf · 2025/8/4
• 评级变动
  Freedom Capital Markets Initiates IRadimed(IRMD.US) With Buy Rating, Announces Target Price $116
  \u5e02\u573a\u8d44\u8baf · 2026/4/2
• 评级变动
  Lake Street Maintains IRadimed(IRMD.US) With Buy Rating, Maintains Target Price $70
  \u5e02\u573a\u8d44\u8baf · 2025/5/31
• 评级变动
  Lake Street Maintains IRadimed(IRMD.US) With Buy Rating, Raises Target Price to $120
  \u5e02\u573a\u8d44\u8baf · 2026/2/11
• 评级变动
  Lake Street Maintains IRadimed(IRMD.US) With Buy Rating, Cuts Target Price to $60
  \u5e02\u573a\u8d44\u8baf · 2025/5/6
• Earnings Call Summary | IRadimed(IRMD.US) Q1 2026 Earnings Conference
  \u5e02\u573a\u8d44\u8baf · 2026/5/2
• 评级变动
  Roth MKM Maintains IRadimed(IRMD.US) With Buy Rating, Raises Target Price to $120
  \u5e02\u573a\u8d44\u8baf · 2026/2/11
• 评级变动
  Lake Street Maintains IRadimed(IRMD.US) With Buy Rating, Raises Target Price to $70
  \u5e02\u573a\u8d44\u8baf · 2025/5/7
• 评级变动
  Lake Street Maintains IRadimed(IRMD.US) With Buy Rating, Raises Target Price to $100
  \u5e02\u573a\u8d44\u8baf · 2025/11/4

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。